Worth Watching Stocks: Walgreens Boots Alliance, Inc. (NASDAQ:WBA), AbbVie Inc. (NYSE:ABBV)


Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) represented a move of -3.96 percent or $3.11 per share and closed its previous day trading session at $74.2. 9.17 Million Shares were traded in the last trading session with an Average Volume of 5.8 Million Shares. The stock currently has a Market Capitalization of 69.73 Billion.

Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.

The stock traded between $59.07 and $80.68 over 1-Year time period showing its price to sales ratio of 0.53. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $3.65 and 200-Day Simple Moving Average of $8.68. Its Price to Free Cash Flow is 13.52 and Price to Book of 2.78.

Analyst’s recommended the stock as 2.7 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Walgreens Boots Alliance, Inc. (NASDAQ:WBA) reported its Actual EPS of $1.48/share. The analysts offering Earnings Estimates for the company were believing that Walgreens Boots Alliance, Inc. could bring EPS of $1.45/share. The difference between Actual EPS and Estimated EPS was 0.03 Percent. Thus showing an Earnings Surprise of 2.1 Percent.

AbbVie Inc. (NYSE:ABBV)

In the last trading session, AbbVie Inc. (NYSE:ABBV) added its value by -4.28% closing at the price of $79.41. The stock currently has market capitalization of 122.89 Billion, with average volume of 5.42 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently AbbVie Inc. (NYSE:ABBV) is showing beta of 1.49. This particular value of beta suggests that AbbVie Inc. (NYSE:ABBV) has historically moved 149% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for AbbVie Inc. (NYSE:ABBV) is at $4.29.

The stock currently has RSI of 20.97. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie aims to help patients’ live healthier lives and collaborate on sustainable healthcare solutions.

AbbVie Inc. (NYSE:ABBV) topped its 52-week high price of $125.86 on 01/26/18 and 52-Week Low Price of $ 79.26 on 10/24/18. The Stock currently has P/E (price to earnings ttm) of 18.53 and Weekly volatility of 4.11% and monthly volatility of 2.56% respectively.